https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
(MedPage Today) — Hospitals’ adoption of biosimilars for three oncology biologics increased dramatically over a 5-year period, as did the facilities’ profit margins on the drugs, claims and drug acquisition data showed.
Adoption of the biosimilars…
